Logo image
IRO Home Research units Researcher Profiles
Sign in
Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate
Journal article   Peer reviewed

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate

Brian L Swick, Larisa Ravdel, James E Fitzpatrick and William A Robinson
Journal of cutaneous pathology, Vol.35(2), pp.197-202
02/2008
DOI: 10.1111/j.1600-0560.2007.00793.x
PMID: 18190445

View Online

Abstract

Immunohistochemistry Skin Neoplasms - drug therapy Humans Carcinoma, Merkel Cell - genetics Antineoplastic Agents - therapeutic use Piperazines - therapeutic use Imatinib Mesylate Carcinoma, Merkel Cell - drug therapy Pyrimidines - therapeutic use Receptor, Platelet-Derived Growth Factor alpha - genetics Skin Neoplasms - genetics Polymerase Chain Reaction Benzamides Mutation

Details

Metrics

Logo image